User profiles for "author:Iain Sainsbury"
 | Iain SainsburyVerified email at sainsbury.me.uk Cited by 102 |
Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early …
A Kavanaugh, RF van Vollenhoven… - Annals of the …, 2018 - ard.bmj.com
Objectives To compare responses in patients with early rheumatoid arthritis (RA) initially
treated with the tumour necrosis factor inhibitor (TNFi) adalimumab+ methotrexate (MTX) …
treated with the tumour necrosis factor inhibitor (TNFi) adalimumab+ methotrexate (MTX) …
Landscape narratives: the south east Cheviots project
P Topping, K Blood, M Bowden, A Carter… - Proceedings of the …, 2008 - cambridge.org
'The huts are now roofless, the fires of the hearths quenched for ever, the fortifications
levelled; yet these ruins have out-lasted the erections of more civilized times, and they still …
levelled; yet these ruins have out-lasted the erections of more civilized times, and they still …
[HTML][HTML] Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical …
J Smolen, R Fleischmann, D Aletaha, Y Li… - Arthritis Research & …, 2019 - Springer
Background The ACR20 has been validated as the best discriminator of efficacy in placebo-
controlled trials, but not in head-to-head trials comparing effective therapies in patients with …
controlled trials, but not in head-to-head trials comparing effective therapies in patients with …
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis
EC Keystone, FC Breedveld, H Kupper, Y Li… - RMD open, 2018 - rmdopen.bmj.com
Objective To evaluate long-term clinical, functional and radiographic outcomes in an open-
label extension (OLE) study in patients with rheumatoid arthritis (RA) receiving adalimumab …
label extension (OLE) study in patients with rheumatoid arthritis (RA) receiving adalimumab …
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate …
EC Keystone, FC Breedveld, D Van Der Heijde… - RMD open, 2017 - rmdopen.bmj.com
Objective To evaluate the achievement of comprehensive disease control (CDC) following 1
year of treatment with adalimumab+ methotrexate versus methotrexate alone and whether …
year of treatment with adalimumab+ methotrexate versus methotrexate alone and whether …
AB0315 Reduction of Concomitant Oral Methotrexate or Corticosteroids in Combination Treatment with Adalimumab Does Not Affect Effectiveness in Patients with …
E Keystone, F Breedveld, A Kavanaugh, Y Zhang… - 2016 - ard.bmj.com
Background In rheumatoid arthritis (RA) patients (pts) receiving corticosteroids (CS) or
methotrexate (MTX) with an anti-TNF, such as adalimumab (ADA), the concomitant CS or …
methotrexate (MTX) with an anti-TNF, such as adalimumab (ADA), the concomitant CS or …
THU0185 The value of adalimumab trough levels and clinical assessments in predicting clinical response in patients with established rheumatoid arthritis and an …
J Smolen, N Mostafa, X Huang, P Noertersheuser… - 2018 - ard.bmj.com
Background Low trough levels of the tumour necrosis factor inhibitor, adalimumab (ADL),
and anti-ADL antibodies (AAA) were reported to be correlated with lack of response at later …
and anti-ADL antibodies (AAA) were reported to be correlated with lack of response at later …
[CITATION][C] The Roman fort at Bewcastle: an analytical field survey
I Sainsbury, H Welfare - Transactions of the Cumberland and Westmorland …, 1990
[CITATION][C] BY PETER TOPPING¹
TP McOMISH, I SAINSBURY… - Proceedings …, 1936 - University Museum of Archaeology …
[CITATION][C] The role of fibroblasts in aseptic prosthesis loosening.
ISS Sainsbury - 1999 - University of Bristol